List of chemotherapy regimens

Jump to navigation Jump to search

WikiDoc Resources for List of chemotherapy regimens

Articles

Most recent articles on List of chemotherapy regimens

Most cited articles on List of chemotherapy regimens

Review articles on List of chemotherapy regimens

Articles on List of chemotherapy regimens in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on List of chemotherapy regimens

Images of List of chemotherapy regimens

Photos of List of chemotherapy regimens

Podcasts & MP3s on List of chemotherapy regimens

Videos on List of chemotherapy regimens

Evidence Based Medicine

Cochrane Collaboration on List of chemotherapy regimens

Bandolier on List of chemotherapy regimens

TRIP on List of chemotherapy regimens

Clinical Trials

Ongoing Trials on List of chemotherapy regimens at Clinical Trials.gov

Trial results on List of chemotherapy regimens

Clinical Trials on List of chemotherapy regimens at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on List of chemotherapy regimens

NICE Guidance on List of chemotherapy regimens

NHS PRODIGY Guidance

FDA on List of chemotherapy regimens

CDC on List of chemotherapy regimens

Books

Books on List of chemotherapy regimens

News

List of chemotherapy regimens in the news

Be alerted to news on List of chemotherapy regimens

News trends on List of chemotherapy regimens

Commentary

Blogs on List of chemotherapy regimens

Definitions

Definitions of List of chemotherapy regimens

Patient Resources / Community

Patient resources on List of chemotherapy regimens

Discussion groups on List of chemotherapy regimens

Patient Handouts on List of chemotherapy regimens

Directions to Hospitals Treating List of chemotherapy regimens

Risk calculators and risk factors for List of chemotherapy regimens

Healthcare Provider Resources

Symptoms of List of chemotherapy regimens

Causes & Risk Factors for List of chemotherapy regimens

Diagnostic studies for List of chemotherapy regimens

Treatment of List of chemotherapy regimens

Continuing Medical Education (CME)

CME Programs on List of chemotherapy regimens

International

List of chemotherapy regimens en Espanol

List of chemotherapy regimens en Francais

Business

List of chemotherapy regimens in the Marketplace

Patents on List of chemotherapy regimens

Experimental / Informatics

List of terms related to List of chemotherapy regimens

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Chemotherapy regimens are often identified with acronyms, identifying the agents used in combination. Unfortunately, the letters used are not consistent across regimens, and in some cases (for example, "BEACOPP") the same letter is used to represent two different treatments. Because of this, there is not a naming standard for chemotherapy regimens, and this page merely represents commonly used conventions.

The term "Induction regimens" refers to a chemotherapy regimen which is used for the initial treatment of a disease.

Name Components Example of uses, and other notes
ABVD [1] Adriamycin, bleomycin, vinblastine, dacarbazine Hodgkin's lymphoma
AC Adriamycin/Doxorubicin, Cyclophosphamide Breast cancer
BEACOPP [2] Bleomycin, etoposide, Adriamycin (doxorubicin), cyclophosphamide, Oncovin (vincristine), procarbazine, prednisone Hodgkin's lymphoma
BEP Bleomycin, etoposide, platinum (cisplatin) Testicular cancer, germ cell tumors
CAF Cyclophosphamide, Adriamycin/Doxorubicin, 5-FU/Fluorouracil Breast cancer
CAV Cyclophosphamide, Adriamycin/Doxorubicin, Vincristine Lung cancer
CHOP Cyclophosphamide, doxorubicin (hydroxydoxorubicin), vincristine (Oncovin), prednisone Non-Hodgkin lymphoma
CHOP-R CHOP + rituximab B cell non-Hodgkin lymphoma
COP or CVP Cyclophosphamide, vincristine (Oncovin), and prednisone Non-Hodgkin lymphoma in patients with history of cardiovascular disease
CMF Cyclophosphamide, Methotrexate, and 5-Fluorouracil Breast Cancer
COPP Cyclophosphamide, Oncovin (vincristine), procarbazine and prednisone Non-Hodgkin lymphoma
DA-EPOCH [3] Dose-adjusted Etopiside, prednisone, vincristine (Oncovin), Cyclophosphamide and doxorubicin Newly diagnosed, aggressive non-Hodgkin lymphoma
DHAP [4] Dexamethasone, cytarabine (high-dose ARA-C), cisplatin Recurrent or refractory non-Hodgkin lymphoma
EC Epirubicin, Cyclophosphamide Breast cancer
ECF Epirubicin, cisplatin, fluorouracil Gastric cancer and oesophageal cancer
ESHAP Etopiside, methylprednisolone (Solu-medrol), cytarabine (ARA-C), cisplatin Relapsed or refractory non-Hodgkin lymphoma
FN-D [5] Fludarabine, mitoxantrone (Novantrone), dexamethasone Recurrent or refractory indolent non-Hodgkin lymphoma
FOLFOX Fluorouracil, leucovorin (folinic acid), and oxaliplatin Colorectal cancer
HYPER-CVAD [6] Hyperfractionated cyclophosphamide, vincristine (Oncovin), doxorubicin (Adriamycin), dexamethasone (Decadron) Burkitt's lymphoma
ICE [7]' Ifosfamide, carboplatin, etopiside Relapsed or primary refractory non-Hodgkin lymphoma
ICE-R ICE + rituximab Relapsed or primary refractory non-Hodgkin lymphoma
m-BACOD Methotrexate, bleomycin, doxorubicin (Adriamycin), cyclophosphamide, vincristine (Oncovin), dexamethasone (Decadron) Non-Hodgkin lymphoma
MACOP-B [8] Methotrexate, leucovorin, doxorubicin (Adriamycin), cyclophosphamide, vincristine (Oncovin), prednisone, bleomycin Non-Hodgkin lymphoma
MOPP Mechlorethamine, vincristine (oncovin), procarbazine, prednisone Hodgkin's lymphoma
NABTT [9] Methotrexate, calcium leucovorin; methotrexate, calcium leucovorin; methotrexate, calcium leucovorin Primary CNS lymphoma
PCV Procarbazine, lomustine (CCNU), vincristine Brain tumors
ProMACE-MOPP Methotrexate, doxorubicin (Adriamycin), cyclophosphamide, etoposide + MOPP Non-Hodgkin lymphoma
ProMACE-CytaBOM Prednisone, doxorubicin (adriamycin), cyclophosphamide, etoposide, cytarabine, bleomycin, vincristine (Oncovin), methotrexate, leucovorin Non-Hodgkin lymphoma
R-FCM Rituximab, fludarabine, cyclophosphamide, mitoxantrone B cell non-Hodgkin lymphoma
RTOG 93-10 [10] Methotrexate, Leucovorin, vincristine, procarbazine, methotrexate, Leucovorin Primary CNS lymphoma
Stanford V [11] Doxorubicin (Adriamycin), mechlorethamine, bleomycin, vinblastine, vincristine (Oncovin), etoposide (VP-16), prednisone Hodgkin's lymphoma
Thal/Dex Thalidomide, dexamethasone Multiple myeloma
VAD Vincristine, Adriamycin (doxorubicin), dexamethasone Multiple myeloma
  1. Bonadonna G, Zucali R, Monfardini S, De Lena M, Uslenghi C (1975). "Combination chemotherapy of Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide versus MOPP". Cancer. 36 (1): 252–9. PMID 54209. Unknown parameter |month= ignored (help)
  2. Diehl V, Franklin J, Hasenclever D; et al. (1998). "BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group". J. Clin. Oncol. 16 (12): 3810–21. PMID 9850026. Unknown parameter |month= ignored (help)
  3. Wilson WH, Grossbard ML, Pittaluga S; et al. (2002). "Dose-adjusted EPOCH chemotherapy for untreated large B-cell lymphomas: a pharmacodynamic approach with high efficacy". Blood. 99 (8): 2685–93. PMID 11929754. Unknown parameter |month= ignored (help)
  4. Velasquez WS, Cabanillas F, Salvador P; et al. (1988). "Effective salvage therapy for lymphoma with cisplatin in combination with high-dose Ara-C and dexamethasone (DHAP)". Blood. 71 (1): 117–22. PMID 3334893. Unknown parameter |month= ignored (help)
  5. McLaughlin P, Hagemeister FB, Romaguera JE; et al. (1996). "Fludarabine, mitoxantrone, and dexamethasone: an effective new regimen for indolent lymphoma". J. Clin. Oncol. 14 (4): 1262–8. PMID 8648382. Unknown parameter |month= ignored (help)
  6. Thomas DA, Cortes J, O'Brien S; et al. (1999). "Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia". J. Clin. Oncol. 17 (8): 2461–70. PMID 10561310. Unknown parameter |month= ignored (help)
  7. Moskowitz CH, Bertino JR, Glassman JR; et al. (1999). "Ifosfamide, carboplatin, and etoposide: a highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma". J. Clin. Oncol. 17 (12): 3776–85. PMID 10577849. Unknown parameter |month= ignored (help)
  8. Klimo P, Connors JM (1985). "MACOP-B chemotherapy for the treatment of diffuse large-cell lymphoma". Ann. Intern. Med. 102 (5): 596–602. PMID 2580468. Unknown parameter |month= ignored (help)
  9. Herrlinger U, Schabet M, Brugger W; et al. (2002). "German Cancer Society Neuro-Oncology Working Group NOA-03 multicenter trial of single-agent high-dose methotrexate for primary central nervous system lymphoma". Ann. Neurol. 51 (2): 247–52. PMID 11835382. Unknown parameter |month= ignored (help)
  10. DeAngelis LM, Seiferheld W, Schold SC, Fisher B, Schultz CJ (2002). "Combination chemotherapy and radiotherapy for primary central nervous system". J. Clin. Oncol. 20 (24): 4643–8. PMID 12488408. Text " lymphoma: Radiation Therapy Oncology Group Study 93-10 " ignored (help); Unknown parameter |month= ignored (help)
  11. Bartlett NL, Rosenberg SA, Hoppe RT, Hancock SL, Horning SJ (1995). "Brief chemotherapy, Stanford V, and adjuvant radiotherapy for bulky or advanced-stage Hodgkin's disease: a preliminary report". J. Clin. Oncol. 13 (5): 1080–8. PMID 7537796. Unknown parameter |month= ignored (help)

See also

External links

Template:Chemotherapeutic Agents Template:SIB

Template:WS